ES2060737T3 - Procedimiento de preparacion de un granulado farmaceutico. - Google Patents

Procedimiento de preparacion de un granulado farmaceutico.

Info

Publication number
ES2060737T3
ES2060737T3 ES89200430T ES89200430T ES2060737T3 ES 2060737 T3 ES2060737 T3 ES 2060737T3 ES 89200430 T ES89200430 T ES 89200430T ES 89200430 T ES89200430 T ES 89200430T ES 2060737 T3 ES2060737 T3 ES 2060737T3
Authority
ES
Spain
Prior art keywords
granulate
preparing
procedure
wet
pharmaceutical granulate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89200430T
Other languages
English (en)
Inventor
Margaretha Olthoff
Bernardus Leonardus Dijkgraaf
Piet Johannes Akkerboom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Europe BV
Original Assignee
Yamanouchi Europe BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Europe BV filed Critical Yamanouchi Europe BV
Application granted granted Critical
Publication of ES2060737T3 publication Critical patent/ES2060737T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UN GRANULADO MOJADO ES PROPORCIONADO CONTENIENDO UNA SUSTANCIA TERAPEUTICAMENTE UTIL TENIENDO UNA SOLUBILIDAD AL AGUA DE 10% O MENOR Y CELULOSA MICROCRISTALINA O MICROFINA, O UNA MEZCLA DE AMBOS, CARACTERIZADO EN QUE LAS CANTIDADES SUSTANCIALES DE LIGANTES EN MOJADO SE ELUDEN. LA MEZCLAS DE PASTILLAS CON EL NUEVO GRANULADO POSEEN UN MODELO DE BUEN FLUJO Y PUEDEN SER COMPRIMIDAS EN TABLETAS QUE MUESTRAN UNA EXCELENTE CONDUCTA DE DESINTEGRACION.
ES89200430T 1988-02-25 1989-02-20 Procedimiento de preparacion de un granulado farmaceutico. Expired - Lifetime ES2060737T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP88200346 1988-02-25

Publications (1)

Publication Number Publication Date
ES2060737T3 true ES2060737T3 (es) 1994-12-01

Family

ID=8199757

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89200430T Expired - Lifetime ES2060737T3 (es) 1988-02-25 1989-02-20 Procedimiento de preparacion de un granulado farmaceutico.

Country Status (17)

Country Link
US (1) US5085869A (es)
EP (1) EP0330284B1 (es)
JP (1) JP2939262B2 (es)
KR (1) KR0135289B1 (es)
CN (1) CN1048395C (es)
AT (1) ATE108996T1 (es)
AU (1) AU611999B2 (es)
CA (1) CA1338553C (es)
DE (1) DE68916983T2 (es)
DK (1) DK175306B1 (es)
ES (1) ES2060737T3 (es)
FI (1) FI100219B (es)
IE (1) IE69366B1 (es)
IL (1) IL89378A (es)
NO (1) NO178485C (es)
NZ (1) NZ228122A (es)
PT (1) PT89823B (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1246188B (it) * 1990-07-27 1994-11-16 Resa Farma Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute.
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
MY110880A (en) * 1991-01-30 1999-06-30 The Wellcome Foundation Ltd Water-dispersible tablets
DE69331839T2 (de) * 1992-01-29 2002-12-12 Takeda Chemical Industries Ltd Schnellösliche Tablette und ihre Herstellung
EP0560092B1 (de) * 1992-03-11 1997-12-03 ASTA Medica Aktiengesellschaft Tabletten, Granulate und Pellets mit hohem Gehalt an Wirkstoffen für hochkonzentrierte, feste Darreichungsformen
JP2964195B2 (ja) * 1992-04-28 1999-10-18 エスエス製薬株式会社 ピロキシカム錠及びその製造法
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
CA2159419C (en) * 1994-10-17 2006-07-04 Pieter De Haan Solid pharmaceutical composition comprising an excipient capable of binding water
SE504902C2 (sv) * 1994-11-02 1997-05-26 Diabact Ab Beredning för påvisande av Helicobacter pylori i magsäcken
BR9607189A (pt) * 1995-02-08 1997-11-11 Yamanouchi Europ Bv Formas de dosagem oral contendo um antibiótico de b-lactama
TWI225402B (en) * 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
US5837292A (en) * 1996-07-03 1998-11-17 Yamanouchi Europe B.V. Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
EP0912169A2 (en) * 1996-07-16 1999-05-06 Gist-Brocades B.V. $g(b)-LACTAM GRANULES FREE OF ORGANIC SOLVENTS
EP0948318B1 (en) * 1996-08-14 2004-03-24 Yamanouchi Europe B.V. Granulates comprising a water soluble compound and cellulose
JPH11506473A (ja) * 1997-02-25 1999-06-08 ザ、プロクター、エンド、ギャンブル、カンパニー 湿式粒状化方法
US5785995A (en) * 1997-04-11 1998-07-28 Upsher-Smith Laboratories, Inc. Pharmaceutical tablet of amiodarone salt
GB9720061D0 (en) 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
AU1150799A (en) * 1997-10-10 1999-05-03 Yamanouchi Europe B.V. Oral compositions containing a cephalosporin antibiotic
FR2772617B1 (fr) * 1997-12-19 2001-03-09 Besins Iscovesco Lab Comprime de progesterone et son procede de preparation
TR200805741T2 (tr) * 1998-12-23 2008-10-21 Novartis Ag At-1 veya at-2 reseptörlerindeki artışın neden olduğu hastalıkların tedavisi için at-1 reseptör antagonisti veya at-2 reseptör modülatörünün kullanımı@
EA003052B1 (ru) 1999-07-27 2002-12-26 Балканфарма Холдинг АД Антиаритмическое лекарственное средство
US20010053791A1 (en) * 2000-03-16 2001-12-20 Babcock Walter C. Glycogen phosphorylase inhibitor
JP2004522752A (ja) * 2001-02-05 2004-07-29 アール．ピー． シェーラー テクノロジーズ インコーポレイテッド 薬学的活性剤の味を軽減するための方法および組成物
MXPA04007428A (es) * 2002-02-01 2004-10-11 Pfizer Prod Inc Formas de dosificacion de liberacion inmediata que contienen dispersiones de farmaco solido.
US6958161B2 (en) * 2002-04-12 2005-10-25 F H Faulding & Co Limited Modified release coated drug preparation
US20050008691A1 (en) * 2003-05-14 2005-01-13 Arturo Siles Ortega Bicalutamide compositions
MY157620A (en) 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
GB0714670D0 (en) * 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) * 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition
FR2991179B1 (fr) 2012-06-01 2016-11-11 Ceva Sante Animale Compositions veterinaires orales appetentes
WO2018011672A1 (en) * 2016-07-13 2018-01-18 Gangwal Chemicals Private Limited Process for directly compressible co-processed excipient for modified release application

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5438167B2 (es) * 1974-04-27 1979-11-19
JPS5562012A (en) * 1978-11-06 1980-05-10 Teijin Ltd Slow-releasing preparation
GB2058565B (en) * 1979-09-21 1983-12-07 Leo Pharm Prod Ltd Layer tablets
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
NZ199931A (en) * 1981-03-13 1985-02-28 Lilly Co Eli Method for formulating medicated animal feed premix comprising a synthetic drug
JPS5839618A (ja) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤
DE3266580D1 (en) * 1981-12-02 1985-10-31 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics
JPS59101423A (ja) * 1982-12-02 1984-06-12 Takada Seiyaku Kk 新規なニフエジピン固形製剤
JPS6097919A (ja) * 1983-11-01 1985-05-31 Furointo Sangyo Kk 圧縮成形用賦形剤の製造方法
NL8400911A (nl) * 1984-03-22 1985-10-16 Dagra Nv Werkwijze ter bereiding van een farmaceutische toedieningsvorm die tetracycline of doxycyclinezouten bevat.
EP0205336B1 (en) * 1985-06-11 1991-09-11 Teijin Limited Oral sustained release pharmaceutical preparation
US4753801A (en) * 1985-10-25 1988-06-28 Eli Lilly And Company Sustained release tablets
GB8618811D0 (en) * 1986-08-01 1986-09-10 Approved Prescription Services Sustained release ibuprofen formulation
DE3887179T2 (de) * 1987-03-02 1994-06-16 Brocades Pharma Bv Pharmazeutische Zusammensetzung, pharmazeutisches Granulat und Verfahren zu ihrer Herstellung.
US4837031A (en) * 1987-09-17 1989-06-06 Mallinckrodt, Inc. Compositions containing ibuprofen
US4837030A (en) * 1987-10-06 1989-06-06 American Cyanamid Company Novel controlled release formulations of tetracycline compounds

Also Published As

Publication number Publication date
AU611999B2 (en) 1991-06-27
IE69366B1 (en) 1996-09-04
NO890789L (no) 1989-08-28
AU3015889A (en) 1989-08-31
FI890884A0 (fi) 1989-02-24
CN1048395C (zh) 2000-01-19
NO178485C (no) 1996-04-10
JP2939262B2 (ja) 1999-08-25
DK175306B1 (da) 2004-08-16
DK86389D0 (da) 1989-02-24
NO890789D0 (no) 1989-02-24
DE68916983T2 (de) 1995-01-19
DK86389A (da) 1989-08-26
CN1035433A (zh) 1989-09-13
KR0135289B1 (ko) 1998-04-23
CA1338553C (en) 1996-08-27
IL89378A (en) 1993-01-31
NO178485B (no) 1996-01-02
EP0330284A2 (en) 1989-08-30
FI890884A (fi) 1989-08-26
US5085869A (en) 1992-02-04
NZ228122A (en) 1991-04-26
IE890545L (en) 1989-08-25
PT89823B (pt) 1994-04-29
PT89823A (pt) 1989-10-04
FI100219B (fi) 1997-10-31
ATE108996T1 (de) 1994-08-15
EP0330284A3 (en) 1990-11-07
KR900012603A (ko) 1990-09-01
DE68916983D1 (de) 1994-09-01
JPH023606A (ja) 1990-01-09
EP0330284B1 (en) 1994-07-27
IL89378A0 (en) 1989-09-10

Similar Documents

Publication Publication Date Title
ES2060737T3 (es) Procedimiento de preparacion de un granulado farmaceutico.
EA199900075A1 (ru) Гранулят для получения быстрораспадающихся и быстрорастворяющихся композиций, содержащих большое количество лекарственного средства
AU588136B2 (en) Spray dried acetaminophen
ES8607009A1 (es) Un metodo para preparar una forma de dosificacion unitaria solida, terapeuticamente activa
PH19749A (en) New optically active 1,4-dihydro-pyridine compounds,their production and their medicinal use
MY117090A (en) Substituted benzamidines, their preparation and their use as pharmaceutical compounds
HK1030604A1 (en) Method for the synthesis of huperzine a and analogs thereof and compounds useful therein
ES525786A0 (es) Un procedimiento para preparar derivados de pirazolo (3,4-b) piridina
USD277171S (en) Bracelet or the like
ATE60713T1 (de) Pharmazeutische zusammensetzung aus guar-gummi und anderen antiacida zum schutz der oeso-gastro- duodenalen schleimhaut.
ATE92752T1 (de) Spruehgetrocknete ibuprofen-zusammensetzungen.
IL78017A0 (en) Sustained release tablets of theophylline
CU21284A3 (en) Procedure to the production of a mixture of methanol and superior alcohols "combustible grade"
SE8703889D0 (sv) Sustained release pharmaceutical compositions
ZA905932B (en) 14,17alpha-etheno-and-ethanoestratrienes,processes for the preparation of these compounds,as well as their use for the production of medicinal agents
IL87712A0 (en) Anxiolytic pharmaceutical compositions containing piperazine derivatives
FI885506A (fi) Farmaceutisk komposition och foerfarande foer framstaellning daerav.
DE69717253T2 (de) Captopriltabletten
MX12192A (es) Composicion farmaceutica para reducir o impedir las arritmias
RU1819933C (ru) Понур
RU93006370A (ru) Способ получения лекарственного препарата п.и.федорищева
DE68900695D1 (de) Anti-asthenische zusammensetzung, ihr herstellungsverfahren und ihre verwendung.
ES2008576A6 (es) Metodo de fabricacion de feretros.
ATE11639T1 (de) Pharmazeutische zusammensetzungen zur schmerzbekaempfung.